Please cite this article as: Manninen S, Lankinen M, Erkkilä A, Nguyen SD, Ruuth M, de Mello V, Öörni K, Schwab U, The effect of intakes of fish and Camelina sativa oil on atherogenic and antiatherogenic functions of LDL and HDL particles: A randomized controlled trial, Atherosclerosis, https:// Abstract 1 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 2 Background and aims: Omega-3 fatty acids are known to have several cardioprotective 2 effects. Our aim was to investigate the effects of intakes of fish and Camelina sativa oil 3 (CSO), rich in alpha-linolenic acid, on the atherogenic and anti-atherogenic functions of LDL 4 and HDL particles.
Progression of atherosclerosis consists of several molecular and inflammatory processes, 27 taking place in the arterial wall [1] [2] [3] . The initiating process in atherogenesis is retention of 28 lipoproteins, mainly LDL particles, in the arterial intima. Lipoproteins containing 29 apolipoprotein B (apoB) and apoE bind to proteoglycans of the intimal layer and can be 30 modified, e.g. by oxidation and lipolysis. Modified lipoproteins may further aggregate or fuse 31 [4] , which increases their binding strength to proteoglycans [5, 6] and prevents their exit back 32 to the bloodstream [7] . The aggregation susceptibility of LDL varies among individuals and 33 was recently shown to associate with cardiovascular deaths [8] . LDL, particularly when 34 modified, also stimulate several atherogenic processes, such as interleukin-8 (IL-8) secretion 35 of endothelial cells, which induce the chemotactic recruitment of monocytes to the arterial 36 intima [1, 9, 10] . Modified lipoproteins are taken up by macrophages, which leads to foam- 37 cell formation. Retained and modified lipoproteins and foam cell formation leads to the 38 release of proinflammatory cytokines and bridging molecules (e.g. lipoprotein lipase), 39 smooth muscle cell proliferation, induced synthesis of proteoglycans and eventually further 40 entrapment of lipoproteins [4, 11] . These reactions trigger a self-accelerating process that 41 eventually leads to progression of atherosclerosis.
are key mediators of their atheroprotective functions. Examples of structural components, 48 which can mediate HDL function, are apoE and serum amyloid A (SAA) [14, 15] . ApoE is
known to have several anti-atherogenic functions such as mediating plasma lipoprotein 50 clearance by the liver [14] . Furthermore, apoE has been shown to contribute to lipid retention 51 via HDL [16] . HDL particles containing apoE can bind to proteoglycans and, therefore,
52
interfere with the formation of LDL-proteoglycan complex. This competition of binding sites 53 could potentially prevent LDL accumulation in the arterial wall. Another component which 54 could impair the atheroprotective functions of HDL is SAA, which is carried primarily in 55 HDL particles in plasma [15] . SAA is considered a potential mediator of atherosclerosis by 56 acting as a bridging protein between lipoproteins and proteoglycans and impairing cholesterol 57 efflux capacity.
59
Diet is an important modifiable lifestyle factor in the prevention of CVD [17, 18] . Among the 60 beneficial dietary factors, fish has been considered as an important component in a 61 cardioprotective diet. Fish, especially fatty fish, is a rich source of n-3 polyunsaturated fatty 62 acids (n-3 PUFAs), which have been shown to affect several molecular mechanisms and 63 pathways related to CVD, such as physical and chemical properties of cellular membranes, 64 inflammation and regulation of gene expression [19] . Previous studies have shown that intake 65 of n-3 PUFAs from fish increases HDL cholesterol level but has no effect on LDL cholesterol 66 [20] whereas evidence on the effects of plant-derived n-3 fatty acid, alpha-linolenic acid 67 (ALA), on serum lipids is inconsistent [21] . In addition to fatty fish, also lean fish intake has 68 been found to have cardioprotective effects [22] [23] [24] . This suggests that the beneficial effects Details of the subjects, study design and recruitment were described previously [25] . Briefly, 85 volunteers aged 40 to 75 years and with impaired glucose metabolism were recruited from 86 Kuopio area. Glucose metabolism was one of the primary endpoints in this study and, 87 therefore, the main inclusion criterion was fasting plasma glucose concentration 5.6-6.9 The study diets were isocaloric and current nutrient recommendations [26] were followed 98 except for fish and ALA intakes. Fish diets included four fish meals per week, e.g. salmon,
99
Baltic herring and vendace in the fatty fish group providing around 1 g of EPA+DHA per day have been reported previously [25] .
114
The blood samples were drawn after 10-hour overnight fasting at baseline (0 wk) and at the 115 end of the study (12 wk). Physical activity, alcohol intake, smoking, body weight and use of 116 medications known to affect the measures of lipid metabolism were to be kept constant 117 during the study. As an objective measure of compliance, the proportions of plasma fatty 118 acids in phospholipids were measured using gas chromatography as previously described [28] 119 with an exception of using C19:0 as an internal standard instead of C17:0. aggregation by human recombinant sphingomyelinase as previously described [8] . LDL 139 aggregation was followed by measuring the particle size using dynamic light scattering. throughput proton NMR spectroscopy, method has been described in detail previously [32] . 
Characteristics of the participants and compliance
212 Mean (± SD) age of the study subjects was 58.9 ± 6.5 years. Baseline characteristics of the 213 study subjects are shown in Supplementary Table 1 . Compliance with the study diets was with the CSO and control groups. Similar changes were also observed in the proportions of 220 these fatty acids in plasma cholesteryl esters, triglycerides and erythrocyte membranes [33] . 
LDL aggregation 231
The susceptibility of LDL to aggregation has recently been shown to differ significantly 232 among human donors and to be associated with cardiovascular deaths [8] . Here, we again 233 found significant individual differences in LDL aggregation, but found no statistically 
Activation of endothelial cells 238
A previous study has shown that modulation of LDL lipid composition influences the ability 239 of LDL to induce secretion of IL-8 from endothelial cells [10] . We determined the IL-8 level 240 upon treatment of human coronary artery endothelial cells with LDL (50 µl/ml) isolated from 241 0-week and 12-week samples. We found that dietary intervention did not influence the ability 242 of LDL to stimulate IL-8 release (Fig. 1C) , indicating that diet intervention does not affect 243 the pro-inflammatory properties of LDL particles as determined by IL-8 secretion. 246 We examined whether diet intervention would modulate the ability of HDL particles to 247 promote cholesterol efflux. To this end, we isolated HDL particles from plasma in the same 248 subjects before and after 12 weeks of fatty fish intervention and determined their cholesterol 249 efflux from human primary foam cells. As shown in Fig. 1D , fatty fish treatment after 12 250 weeks did not significantly affect the cholesterol efflux capacity of HDL. 
Cholesterol efflux capacity

Discussion
268
In this study, we investigated the effect of fish and CSO intakes on binding of lipoproteins to 269 proteoglycans, LDL aggregation, cholesterol efflux capacity and activation of endothelial 270 cells. This is the first dietary intervention study to investigate all these lipoprotein functions 271 in humans. We showed that intake of 30 ml (27 g) of CSO rich in ALA decreases the binding 272 of lipoproteins to aortic proteoglycans compared with the fatty fish group. Previously, Jones 273 et al. [34] found that corn/safflower oil and high-oleic canola oil decreased slightly the 274 binding of LDL to biglycan. In the present study, we used whole plasma samples instead of 275 isolated LDL particles. In this way, we were able to assess the effect of all plasma 276 lipoproteins on cholesterol accumulation to proteoglycans. We have previously shown that 277 intake of CSO decreases serum LDL cholesterol compared with the fatty fish and lean fish 278 groups and IDL particle concentration compared with the lean fish group [25, 32] . Taken [8] . Here, we found no change in the LDL aggregation among 287 the groups, but it should be noted that the individual differences in LDL aggregation were 288 large, as also reported earlier [8] . In that study, the diet-induced differences in LDL 289 aggregation were shown to be due to differences in the surface lipids of LDL, so that a Modulation of LDL lipid composition has previously been shown to induce the release of IL-299 8 from endothelial cells [10, 36] . In these studies, changes in the LDL lipidome were induced 300 enzymatically and increased content of free fatty acids and lysophosphatidylcholine was 301 found to enhance IL-8 release. Instead, studies investigating dietary effects on LDL lipidome 302 are scarce [8, 37] , and to our knowledge, there are no previous studies investigating the 303 effects of dietary intervention on inflammatory properties of LDL particles. Padro et al. [37] 304 found that milk enriched with long-chain n-3 PUFA (0.375 g/250 ml milk) did not induce 305 changes among lipid species of LDL. N-3 enriched milk, however, increased long-chain n-3 306 PUFA content in cholesteryl esters, phosphatidylcholine and PC36:5/lysoPC16:0 ratio.
307
Authors concluded that these changes may be associated with reduced inflammatory activity of LDL particles. Here, we found no change in the ability of LDL to release IL-8.
M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT 16 Previous research on the effects of n-3 fatty acids on cholesterol efflux has been controversial 311 [38] [39] [40] [41] . In experimental models, where macrophages have been directly exposed to EPA, 312 cholesterol efflux capacity has been reduced [38, 39] , whereas EPA-supplementation with a 313 high dose (1.8 g/day) has been shown to enhance cholesterol efflux capacity of HDL from 314 THP-1 macrophages in patients with coronary risk factors [40] . In the present study, the 315 dietary intake of EPA in the fatty fish group was considerably lower: approximately 0.5 g/day 316 [25] . Here, we found that intake of fatty fish had no effect on the cholesterol efflux capacity 317 of HDL particles isolated from plasma. Furthermore, ALA-treatment has been found to 318 increase cholesterol efflux capacity in foam cells by decreasing stearoyl CoA desaturase 1 319 expression [41] . Thus, it appears that ALA-treatment may be able to influence the properties 320 of macrophages rather than that of HDL particles. Overall, further studies are needed to 321 elucidate the role of dietary n-3 PUFAs on cholesterol efflux capacity.
322 323 SAA and apoE are known to contribute to atherosclerosis [14, 15] . SAA has been shown to 324 have several atherogenic functions whereas apoE is best recognized for its anti-atherogenic 325 properties. Both SAA and apoE are also potential mediators in the binding of HDL to 326 proteoglycans [16, 42] . HDL 2 has been found to inhibit the formation of the LDL-327 proteoglycan complex more efficiently than HDL 3 . This is explained by the higher apoE 328 content in large HDL particles compared with small HDL particles [43] . Here, we found no • Intakes of camelina oil or fish have no effect on LDL aggregation
• Intake of fatty fish has no effect on cholesterol efflux capacity of HDL
